FDA Inspection 1002004 — Yale New Haven Health, Lawrence & Memorial Hospital
The FDA completed an inspection of Yale New Haven Health, Lawrence & Memorial Hospital on February 24, 2017 in New London, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 24, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- New London, CT (United States)